Comparison of two selective muscarinic receptor antagonists (solifenacin and darifenacin) in women with overactive bladder - the SOLIDAR study;Usporedba Dva Selektivna Antimuskarinska Lijeka (Solifenacin I Darifenacin) U Žena S Prekomjerno Aktivnim Mokraćnim Mjehurom

Collegium Antropologicum

Volumn 36, Issue 4, 2012, Pages 1347-1353

  But, Igor ^a   Goldštajn, Marina Šprem ^b   Orešković, Slavko ^b  

^a UNIVERSITY OF MARIBOR   (Slovenia)

^b KBC Zagreb   (Croatia)

Author keywords

Anticholinergic; Muscarinic receptors; Overactive bladder; Quality of life

Indexed keywords

EID: 84872282388     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. WEIN AJ, Urology, 62 (2003) 20.
2. HU TW, WAGNER TH, BENTKOVER JD, Urology, 61 (2003) 1123.
3. MILSOM I, ABRAMS P, CARDOZO L, BJU Int, 87 (2001) 760.
4. STEWART WF, VAN ROOYEN JB, CUNDIFF GW, World J Urol, 20 (2003) 327.
5. VERSI E, Int Urogynecol J, 12 (2001) 13.
6. JACKSON D, Urology, 50 (1997) 18.
7. ABRAMS P, KELLEHER CJ, KERR LA, Am J Manag Care, 6 (2000) 580.
8. IRWIN DE, MILSOM I, KOPP Z, BJU Int, 97 (2006) 96.
9. GARELY AD, BURROWS LJ, Expert Opin Pharmacother, 3 (2002) 827.
10. CHAPPLE CR, Urology, 55 (2000) 33.
11. HERBISSON P, HAY-SMITH J, ELLIS G, BMJ, 326 (2003) 841.
12. HAY-SMITH J, HERBISON P, ELLIS G, 3 (2002) CD 003781.
13. KELLEHER CJ, CARDOZO L, CHAPPLE CR, BJU, 95 (2005) 81.
14. KELLEHER CJ, CARDOZO L, KOBASHI K, Int J Urogynecol, 17 (2006) 388.
15. HESCH K, Proc Bayl Univ Med Cent, 20 (2007) 307.
16. HAAB F, Drugs Today, 41 (2005) 441.
17. SHUMAKER SA, WYMAN JF, UEBERSAX JF, Qual Life Res 3 (1994) 291.
18. ABRAMS P, CARDOZO L, FALL M, Neurourol Urodyn, 21 (1994) 167.
19. COYNE KS, PAYNE C, BHATTACHARYYA, Value Health, 7 (2004) 455.
20. KOBAYASHI S, IKEDA K, MIYATA K, Life Sci, 74 (2004) 843.